医療レポート：Idiopathic Pulmonary Fibrosis-疫学予測（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.2.1 There is almost no risk of IPF among long-term heavy smokers 11
3.2.2 Common workplace inhalant pose a large risk in many occupations 11
3.2.3 Gastroesophageal reflux (GER) is common in IPF patients 12
3.3 Global Trends 13
3.3.1 US 13
3.3.2 5EU 14
3.4 Forecast Methodology 15
3.4.1 Sources Used 16
3.4.2 Forecast Assumptions and Methods 18
3.4.3 Sources Not Used 21
3.5 Epidemiology Forecast of Idiopathic Pulmonary Fibrosis (2012–2022) 23
3.5.1 Total Incident Cases of Idiopathic Pulmonary Fibrosis 23
3.5.2 Age-Specific Incident Cases of Idiopathic Pulmonary Fibrosis 25
3.5.3 Sex-Specific Incident Cases of Idiopathic Pulmonary Fibrosis 26
3.5.4 Total Prevalent Cases of Idiopathic Pulmonary Fibrosis 27
3.5.5 Age-Specific Prevalent Cases of Idiopathic Pulmonary Fibrosis 29
3.5.6 Sex-Specific Prevalent Cases of Idiopathic Pulmonary Fibrosis 31
3.6 Discussion 33
3.6.1 Conclusions on Epidemiology Trends 33
3.6.2 Limitations of the Analysis 34
3.6.3 Strengths of the Analysis 34
4 Appendix 35
4.1 Bibliography 35
4.2 About the Authors 37
4.2.1 Epidemiologists 37
4.2.2 Reviewers 37
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis 39
4.2.4 Global Head of Healthcare 39
4.3 About GlobalData 40
4.4 About EpiCast 40
4.5 Contact Us 40
4.6 Disclaimer 41